NICE enough? Do NICE’s Decision Outcomes Impact International HTA Decision-making?
External Expert Profile
Catherine Lichten
Latest Research & Publications
Close
-
All Publications
Filter by:- Antimicrobial Resistance (AMR)
- Biosimilars
- Cell and Gene Therapies
- Chronic Diseases
- Combination Therapies
- COVID-19 Research
- Digital Health
- Drug Development/R&D
- Emerging Markets
- EQ-5D and PROMs
- Health Care Systems
- Health Data and Statistics
- Health Technology Assessment
- Precision Medicine
- Real-World Evidence
- Use of Medicines
- Value-Based Pricing
- Vaccine Research